Adenosine A2B receptor activation stimulates alveolar fluid clearance through alveolar epithelial sodium channel via cAMP pathway in endotoxin-induced lung injury

Clinical studies have established that the capacity of removing excess fluid from alveoli is impaired in most patients with acute respiratory distress syndrome. Impaired alveolar fluid clearance (AFC) correlates with poor outcomes. Adenosine A(2B) receptor (A(2B)AR) has the lowest affinity with adenosine among four adenosine receptors. It is documented that A(2B)AR can activate adenylyl cyclase (AC) resulting in elevated cAMP. Based on the understanding that cAMP is a key regulator of epithelial sodium channel (ENaC), which is the limited step in sodium transport, we hypothesized that A(2B)AR signaling may affect AFC in acute lung injury (ALI) through regulating ENaC via cAMP, thus attenuating pulmonary edema. To address this, we utilized pharmacological approaches to determine the role of A(2B) AR in AFC in rats with endotoxin-induced lung injury and further focused on the mechanisms in vitro. We observed elevated pulmonary A(2B)AR level in rats with ALI and the similar upregulation in alveolar epithelial cells exposed to LPS. A(2B)AR stimulation significantly attenuated pulmonary edema during ALI, an effect that was associated with enhanced AFC and increased ENaC expression. The regulatory effects of A(2B)AR on ENaC-alpha expression were further verified in cultured alveolar epithelial type II (ATII) cells. More importantly, activation of A(2B) AR dramatically increased amiloridesensitive Na+ currents in ATII cells. Moreover, we observed that A(2B)AR activation stimulated cAMP accumulation, whereas the cAMP inhibitor abolished the regulatory effect of A(2B)AR on ENaC-alpha expression, suggesting that A(2B)AR activation regulates ENaC-alpha expression via cAMP-dependent mechanism. Together, these findings suggest that signaling through alveolar epithelial A(2B)AR promotes alveolar fluid balance during endotoxin-induced ALI by regulating ENaC via cAMP pathway, raising the hopes for treatment of pulmonary edema due to ALI.